A Treatment Study for Acute Decompensated Heart Failure

What we are studying

The purpose of this research study is to see whether ularitide is safe and effective for the treatment of a disease called acute decompensated heart failure. The purpose of this research study is to compare one dose of ularitide with a placebo-substance that looks like study treatment, but is medically inactive, to see whether ularitide is safe and effective for the treatment of acute decompensated heart failure.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • Hispanic or Latino
  • Ages 18+

Eligibility Criteria

  • Unplanned hospitalization or emergency department visit for acute heart failure (HF)
  • Evidence of HF on a chest X-ray
  • Systolic blood pressure > 110mmHG
  • Difficulty in breathing a sitting position which has worsened within the last week

What is involved

  • Blood draws
  • Study drug
  • Study assessments performed at varying time points
  • Site visit at day 30
  • Subsequent follow up telephone calls (Day 60
  • Day 90 and Day 180 and every 90 days after the start of study treatment until the end of the study)

Compensation

None

Contact Information

Study Coordinator
Lori Triplett, RN
Email
ltriplet@wakehealth.edu
Phone
336-806-7818
Principal Investigator
Brian Hiestand, MD

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.